Prospective Epigenetic Actions of Organo-Sulfur Compounds against Cancer: Perspectives and Molecular Mechanisms
Cancers · 23.01.2023 · 15 (3) · 697
DOI: 10.3390/cancers15030697 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 23.01.2023. Verfasst von Shoaib Shoaib und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Aligarh Muslim University, Aligarh 202001, Uttar Pradesh, India. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Khalid University.
Abstract (Originalsprache)
Major epigenetic alterations, such as chromatin modifications, DNA methylation, and miRNA regulation, have gained greater attention and play significant roles in oncogenesis, representing a new paradigm in our understanding of cancer susceptibility. These epigenetic changes, particularly aberrant promoter hypermethylation, abnormal histone acetylation, and miRNA dysregulation, represent a set of epigenetic patterns that contribute to inappropriate gene silencing at every stage of cancer progression. Notably, the cancer epigenome possesses various HDACs and DNMTs, which participate in the histone modifications and DNA methylation. As a result, there is an unmet need for developing the epigenetic inhibitors against HDACs and DNMTs for cancer therapy. To date, several epigenetically active synthetic inhibitors of DNA methyltransferases and histone deacetylases have been developed. However, a growing body of research reports that most of these synthetic inhibitors have significant side effects and a narrow window of specificity for cancer cells. Targeting tumor epigenetics with phytocompounds that have the capacity to modulate abnormal DNA methylation, histone acetylation, and miRNAs expression is one of the evolving strategies for cancer prevention. Encouragingly, there are many bioactive phytochemicals, including organo-sulfur compounds that have been shown to alter the expression of key tumor suppressor genes, oncogenes, and oncogenic miRNAs through modulation of DNA methylation and histones in cancer. In addition to vitamins and microelements, dietary phytochemicals such as sulforaphane, PEITC, BITC, DADS, and allicin are among a growing list of naturally occurring anticancer agents that have been studied as an alternative strategy for cancer treatment and prevention. Moreover, these bioactive organo-sulfur compounds, either alone or in combination with other standard cancer drugs or phytochemicals, showed promising results against many cancers. Here, we particularly summarize and focus on the impact of specific organo-sulfur compounds on DNA methylation and histone modifications through targeting the expression of different DNMTs and HDACs that are of particular interest in cancer therapy and prevention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Medicine, Aligarh Muslim University, Aligarh 202001, Uttar Pradesh, India.
- Department of Epidemic Disease Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.
- Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.
- Vaccine and Bioprocessing Center, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Hafr Al Batin, Hafr Al Batin 31991, Saudi Arabia.
- Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
ORCID-Profile: Mohammad Azam Ansari, Mohammed Ghazwani, Umme Hani, Yahya F Jamous, Zahraa Alali, Shadma Wahab, Wasim Ahmad, Sydney A Weir, Mohammad N Alomary, Nabiha Yusuf
Förderung
- King Khalid University
Zitieren
APA
Shoaib, S., Ansari, M. A., Ghazwani, M., Hani, U., Jamous, Y. F., Alali, Z., Wahab, S., Ahmad, W., Weir, S. A., Alomary, M. N., Yusuf, N., & Islam, N. (2023). Prospective Epigenetic Actions of Organo-Sulfur Compounds against Cancer: Perspectives and Molecular Mechanisms. Cancers, 15(3), 697. https://doi.org/10.3390/cancers15030697
Vancouver
Shoaib S, Ansari MA, Ghazwani M, Hani U, Jamous YF, Alali Z, et al. Prospective Epigenetic Actions of Organo-Sulfur Compounds against Cancer: Perspectives and Molecular Mechanisms. Cancers. 2023;15(3):697. doi:10.3390/cancers15030697
BibTeX
@article{Shoaib2023,
author = {Shoaib, Shoaib and Ansari, Mohammad Azam and Ghazwani, Mohammed and Hani, Umme and Jamous, Yahya F and Alali, Zahraa and Wahab, Shadma and Ahmad, Wasim and Weir, Sydney A and Alomary, Mohammad N and Yusuf, Nabiha and Islam, Najmul},
title = {Prospective Epigenetic Actions of Organo-Sulfur Compounds against Cancer: Perspectives and Molecular Mechanisms},
journal = {Cancers},
year = {2023},
volume = {15},
number = {3},
pages = {697},
doi = {10.3390/cancers15030697}
}
EUVIMED